UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Proceedings of the 2023 Viral Clearance Symposium, Session 2: Viral Clearance Strategy and Case Studies

PDA journal of pharmaceutical science and technology, 2024-03, Vol.78 (2), p.147

2024

Volltextzugriff (PDF)

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization

PloS one, 2009-11, Vol.4 (11), p.e7790-e7790

2009

Volltextzugriff (PDF)

N1L Is an Ectromelia Virus Virulence Factor and Essential for In Vivo Spread upon Respiratory Infection

Journal of Virology, 2011-04, Vol.85 (7), p.3557-3569

2011

Volltextzugriff (PDF)

The Orthopoxvirus 68-Kilodalton Ankyrin-Like Protein Is Essential for DNA Replication and Complete Gene Expression of Modified Vaccinia Virus Ankara in Nonpermissive Human and Murine Cells

Journal of Virology, 2009-06, Vol.83 (12), p.6029-6038

2009

Volltextzugriff (PDF)

Strategies toward virus and prion safe human platelet lysates

Transfusion (Philadelphia, Pa.), 2020-01, Vol.60 (1), p.219-220

2020

Volltextzugriff (PDF)

Application of Chimeric Feline Foamy Virus-Based Retroviral Vectors for the Induction of Antiviral Immunity in Cats

Journal of Virology, 2003-07, Vol.77 (14), p.7830-7842

2003

Volltextzugriff (PDF)

The bet Gene of Feline Foamy Virus Is Required for Virus Replication

Virology (New York, N.Y.), 2001-09, Vol.287 (2), p.310-320

2001

Volltextzugriff (PDF)

Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells

Virology (New York, N.Y.), 2010-09, Vol.404 (2), p.231-239

2010

Volltextzugriff (PDF)

Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells

Virology journal, 2013-01, Vol.10 (1), p.34-34, Article 34

2013

Volltextzugriff (PDF)

Cytosolic DNA triggers mitochondrial apoptosis via DNA damage signaling proteins independently of AIM2 and RNA polymerase III

The Journal of immunology (1950), 2012-01, Vol.188 (1), p.394-403

2012

Volltextzugriff (PDF)

Postexposure Immunization with Modified Vaccinia Virus Ankara or Conventional Lister Vaccine Provides Solid Protection in a Murine Model of Human Smallpox

The Journal of infectious diseases, 2009-01, Vol.199 (1), p.39-48

2009

Volltextzugriff (PDF)

The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex

Virology (New York, N.Y.), 2008-05, Vol.374 (2), p.234-239

2008

Volltextzugriff (PDF)

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2α

Journal of general virology, 2010-02, Vol.91, p.470-482

2010

Volltextzugriff (PDF)

Interleukin-1[beta] receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1[beta] activity produced in various virus-infected antigen-presenting cells

Virology journal, 2013-01, Vol.10 (1), p.34-34

2013

Volltextzugriff (PDF)

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model

Journal of general virology, 2010-11, Vol.91 (Pt 11), p.2745-2752

2010

Volltextzugriff (PDF)

NIL Is an Ectromelia Virus Virulence Factor and Essential for In Vino Spread upon Respiratory Infection

Journal of virology, 2011, Vol.85 (7), p.3557-3569

2011

Volltextzugriff (PDF)

Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis

Virology (New York, N.Y.), 2003-06, Vol.310 (2), p.235-244

2003

Volltextzugriff (PDF)

Construction and Functional Characterization of Feline Foamy Virus-Based Retroviral Vectors

Virology (New York, N.Y.), 2002-09, Vol.301 (1), p.53-63

2002

Volltextzugriff (PDF)

Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells

Virus research, 2007-06, Vol.126 (1), p.1-8

2007

Volltextzugriff (PDF)

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2{alpha}

Journal of general virology, 2010-02, Vol.91 (2), p.470-482

2010

Volltextzugriff (PDF)

The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes

Blood, 2006-02, Vol.107 (4), p.1476-1483

2006

Volltextzugriff (PDF)

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H 1 N 1 vaccine in the ferret model

Journal of general virology, 2010, Vol.91, p.2745-2752

2010

Volltextzugriff (PDF)

Preclinical evaluation of influenza vaccines based on replication-deficient poxvirus vector MVA

Procedia in vaccinology, 2011, Vol.4, p.78-83

2011

Volltextzugriff (PDF)

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha

Journal of general virology, 2010-02, Vol.91 (Pt 2), p.470-482

2010

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Virology
(16)
Animals
(14)
Humans
(12)
Mice
(9)
Vaccinia Virus
(9)
Vaccinia Virus - Genetics
(8)
Viral Proteins - Genetics
(7)
Biological And Medical Sciences
(6)
Cell Line
(6)
Amino Acid Sequence
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Microbiology
(5)
Miscellaneous
(5)
Molecular Sequence Data
(5)
Female
(4)
Gene Deletion
(4)
Immunology
(4)
Orthopoxvirus
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Proceedings of the 2023 Viral Clearance Symposium, Session 2: Viral Clearance Strategy and Case Studies

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization

N1L Is an Ectromelia Virus Virulence Factor and Essential for In Vivo Spread upon Respiratory Infection

The Orthopoxvirus 68-Kilodalton Ankyrin-Like Protein Is Essential for DNA Replication and Complete Gene Expression of Modified Vaccinia Virus Ankara in Nonpermissive Human and Murine Cells

Strategies toward virus and prion safe human platelet lysates

Application of Chimeric Feline Foamy Virus-Based Retroviral Vectors for the Induction of Antiviral Immunity in Cats

The bet Gene of Feline Foamy Virus Is Required for Virus Replication

Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells

Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells

Cytosolic DNA triggers mitochondrial apoptosis via DNA damage signaling proteins independently of AIM2 and RNA polymerase III

Postexposure Immunization with Modified Vaccinia Virus Ankara or Conventional Lister Vaccine Provides Solid Protection in a Murine Model of Human Smallpox

The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2α

Interleukin-1[beta] receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1[beta] activity produced in various virus-infected antigen-presenting cells

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model

NIL Is an Ectromelia Virus Virulence Factor and Essential for In Vino Spread upon Respiratory Infection

Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis

Construction and Functional Characterization of Feline Foamy Virus-Based Retroviral Vectors

Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2{alpha}

The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H 1 N 1 vaccine in the ferret model

Preclinical evaluation of influenza vaccines based on replication-deficient poxvirus vector MVA

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha

Suchergebnisse filtern